EULAR 2025 Archives - Medical Conferences

Home > Rheumatology > EULAR 2025

European Alliance of Associations for Rheumatology
11–14 June 2025
Barcelona, Spain

Featured articles

EULAR 2025 Highlights Podcast

Presented By

Dr. Rachel Giles, Robert van den Heuvel, Medicom

Conference

EULAR 2025

30 June 2025 14:25

Gout: novel compound as a future option for refractory patients?

Presented By

Prof. Kenneth G. Saag , University of Alabama at Birmingham, AL, USA

Conference

EULAR 2025

Type

News article

18 June 2025 22:07

Online First

ACPA positivity plus musculoskeletal pain does not equal clinical arthritis over time for all

Presented By

Dr Simon Ahammar, Linköping University, Sweden

Conference

EULAR 2025

Type

News article

20 June 2025 11:34

T2T strategy in gout lowers cardiovascular risk

Presented By

Dr Edoardo Cipolletta , Polytechnic University of Marche, Italy

Type

News article

20 June 2025 11:32

Obinutuzumab shows robust efficacy across different renal endpoints in lupus nephritis

Presented By

Prof. Richard A. Furie , Northwell Health, NY, USA

Trial

REGENCY

Conference

EULAR 2025

Type

News article

20 June 2025 11:30

Bimekizumab provides durable control over 3 years for PsA patients after TNF inhibitor failure

Trial

Phase 3, BE COMPLETE

Conference

EULAR 2025

Type

News article

20 June 2025 11:27

SSc-ILD: Combination of rituximab and mycophenolate mofetil not superior to treatment with either agent alone

Presented By

Dr Devis Benfaremo, Università Politecnica delle Marche, Italy

Conference

EULAR 2025

Type

News article

20 June 2025 11:20

FcRn blockade: a promising targeted treatment option for inflammatory idiopathic myopathy

Presented By

Prof. Hector Chinoy , University of Manchester, United Kingdom

Trial

Phase 2, ALKIVIA

Conference

EULAR 2025

Type

News article

18 June 2025 22:11

Fine particulate matter air pollution linked to increased ANA positivity

Presented By

Dr Sasha Bernatsky, Research Institute of the McGill University Health Centre, Canada

Conference

EULAR 2025

Type

News article

18 June 2025 22:09

Gout: novel compound as a future option for refractory patients?

Presented By

Prof. Kenneth G. Saag , University of Alabama at Birmingham, AL, USA

Conference

EULAR 2025

Type

News article

18 June 2025 22:07

Inhibition of TLR7 and 8: A new way to treat lupus?

Presented By

Prof. Eric Morand , Monash University, Australia

Trial

Phase 2, WILLOW

Conference

EULAR 2025

Type

News article

18 June 2025 22:06

TYK2-inhibition in PsA: zasocitinib shows benefits in minimal disease activity and PASI

Presented By

Dr Alan Kivitz, Altoona Arthritis and Osteoporosis Center in Duncansville, PA, USA

Conference

EULAR 2025

Type

News article

18 June 2025 22:02

Rapid radiographic improvement with IL-23 blockade in biologic-naïve PsA patients

Presented By

Prof. Philip J. Mease, Swedish Medical Center, Seattle, USA

Trial

APEX

Conference

EULAR 2025

Type

News article

18 June 2025 10:28

Use of Axia significantly improves axSpA outcomes

Presented By

Dr Patrick-Pascal Strunz, University Hospital of Würzburg, Germany

Conference

EULAR 2025

Type

News article

18 June 2025 10:24

Beneficial treatment with leflunomide and hydroxychloroquine combination in Sjögren’s Disease

Presented By

Dr Wing-Yi Wong, University Medical Center Utrecht, the Netherlands

Trial

Phase 2, RepurpSS-II

Conference

EULAR 2025

Type

News article

18 June 2025 10:22

A sequential romosozumab-denosumab combination may improve lumbar BMD in glucocorticoid-induced osteoporosis

Presented By

Dr Mai Kawazoe, Toho University School of Medicine, Japan

Conference

EULAR 2025

Type

News article

18 June 2025 10:18

First-in-class oral TYK2 inhibitor shows rapid efficacy in PsA

Presented By

Prof. Désirée van der Heijde, Leiden University Medical Center, the Netherlands

Trial

Phase 3, POETYK PsA-1

Conference

EULAR 2025

Type

News article

18 June 2025 10:15

Featured articles

CONTENTS

Online First